chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Syncope 24 hours post injection,no warning signs,hit head on door frame,hospitalized 4days for cardiac,neuro,testing.All negative findings. 11/27/07 Reviewed hospital medical records which reveal patient experienced a sudden loss of consciousness & fell in doctor's office where patient works.  Sustained a laceration of occiput & was dizzy afterward.  Admitted 10/10-10/13/2007.  Neuro, neurosurgery & cardio consults done.  No recurrent symptoms but continued w/mild dizziness at d/c to home w/neuro f/u for outpatient EEG. FINAL DX: syncope, likely secondary to vasovagal event; mild concussion; scalp laceration./
The patient received her1st dose of Moderna vaccine on 4/14/2021 and a 2nd  dose of Pfizer vaccine was given to her on 5/12/2021 by mistake. The patient was consulted with a medical provider at the vaccine clinic and she was discharged from the clinic without any adverse reactions. The patient was instructed to call our clinic if she experiences any unusual side effects from the injection.
At 1206 while in observation client asked EMT for the restroom and stated she needed to ?throw up?. Client was given an emesis bag. Client stepped outside and sat in gravity chair without assistance. Vitals were taken. Client informed RN that this is a ?normal thing, and it happens all the time? Client gets anxious with vaccines and ?anything medical.? Client informed RN that?s happened with other vaccines. Client denied itchiness, or shortness of breath. At 1213 client stated she felt much better after vomiting and denied having a headache or stomach pain. Client had breakfast before vaccine. Client had one vomiting episode and stated she had chills before vomiting but denied dizziness. Vitals at 1233 BP 99/57 HR 57 02 98% RR 16. Client stated she was feeling ?good? and denied any other symptoms. RN educated client on emergency precautions, and to follow up with her primary care provider. Client verbalized understanding. Client was able to stand from zero gravity chair without assistance and denied any dizziness. Client left vaccination site at 1236 in a steady gait.
After getting the first dose of the vaccine I started to get hives randomly. I got allergy testing which was positive for some things. I tested positive for an allergy to 14 different items. I had no history of allergies besides one reaction 7 years ago. Since getting the first two doses of the vaccine I was getting hives 2-3 times a week. The day after getting the third dose of my vaccine I got a fever of 101.5. I took Tylenol and went to bed. On the second day I woke up with severe swelling and hives around my eyes and on my face. It was much worse on the left side. The hives were all around my eyes and my eyes and eyelids were swollen. I also had Hives and swelling on my upper lip. I took some Benadryl the first two days and the hives and swelling reduced. I consulted my doctor and she told me to take Antihistamines for 30 days. I am taking Loratadine 10mg once daily. The antihistamine worked to keep the reaction under control.  It has only been two weeks.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, drug reaction, allergies or medical history provided. On 18-AUG-2014, the patient was vaccinated with a dose of GARDASIL lot # K003520, expiry date 20-NOV-2016, intramuscularly for prophylaxis. On 29-MAR-2018, the patient was vaccinated with a dose of GARDASIL 9 lot # N020352, expiry date 10-OCT-2020, intramuscularly for prophylaxis. No adverse effects were reported.
right upper extremity edema, pain, erythematosis, following deltoid injection of Pneumococcal vaccine on 05/28/2003.  Patient required Kenalog injection 05/30/2003.  06/01/2003: Patient to ER for IV Decadron, Ancef and MS04.
almost immediately after receiving vax pt was very flushed, dizzy, slightly SOB (x1 min). Sat down. Pulse = 98, SpO2 98, ice pack to chest, MD examined, dizziness resolved after about 2 min SpO2 100% HR 70, no rash, alert, no Resp distress
Approximately 5 hours post vax, the pt made a funny noise. When the mother picked her up she became pale, and lips bluish. The pt resolved immediately.
This case was reported by a consumer via call center representative and described the occurrence of nasal itching in a 5-year-old female patient who received INFANRIX for prophylaxis. Concurrent medical conditions included milk protein allergy (severe). Concomitant products included EPIPEN. On an unknown date, the patient received INFANRIX (intramuscular). On an unknown date, unknown after receiving INFANRIX, the patient experienced nasal itching, runny nose, sneezing and cough. On an unknown date, the outcome of the nasal itching, runny nose, sneezing and cough were recovered/resolved. It was unknown if the reporter considered the nasal itching, runny nose, sneezing and cough to be related to INFANRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had already received 3 doses of INFANRIX since infancy. The patient was due for a booster dose of the INFANRIX at the time of reporting. The patient experienced side effects following the vaccine previously which included itchy and runny nose, sneezing and coughing. The reporter inquired if these side effects occurred each time the patient received this vaccine booster or that she might have had more severe reactions.
Loose stool; This is a spontaneous report from a contactable 38-year-old male Consumer reported for himself that he received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine; Solution for Injection; Lot number: unknown) via unspecified route of administration in the right arm on 18Feb2021 at 09:45 am as a single dose for COVID-19 immunization. Medical history included Attention deficit hyperactivity disorder (ADHD) and allergic to Sulfa. The patient concomitant medications included Melatonin, amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), vitamin D. The patient historical vaccine includes the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine) as a single dose for COVID-19 immunization on 28Jan2021 at 11:15 am in the left arm. On 19Feb2021, at 11:00, the patient experienced loose stools. The patient was not diagnosed with COVID-19, prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any treatment for the adverse event. The clinical outcome for the event was unknown.  Information on the lot/batch number has been requested.
This spontaneous report as received from a nurse practitioner refers to a 12 months old patient of unknown gender. No information on patient's medical history or concurrent conditions was provided. On 30-DEC-2014, the patient was vaccinated with the dose of PEDVAXHIB lot # K008680 (dose, strength, route of administration and expiration date were not reported) which had temperature excursion. No information on patient's concomitant medication was provided. This is one of several reports from the same reporter. Additional information has been requested.
Within 15 -20 minutes of receiving the vaccine, the patient and her mother left the builidng and while in their car, the patient began having muscle rigidity, clonic activity, urinary incontinence.  Total episode lasted approximately 45 seconds.  Mother immediately took patient to the ER of the closest hospital.
pt rcvd vax; pt devel numbness & tingling in left arm; pt devel tingling of lower extremities; pharmacist reported symptoms to be paresthesia;
Vesicle like rash Left thigh where administered. Left abdomen, Left arm, a few areas on Right thigh.
09:28am: Pt received vaccine  09:38am: Pt complained of itchy throat.  (B/P 129/72, pulse = 77, o2 sat = 99% 10:00am:  pt complained itchy throat remains the same.   10:12 am:  Benadryl 10ml give po  x 1 (12.5mg/5ml) 10:20am: Pt states that itchy throat is resolving.   pt discharged.  11:37 am:  contacted pt at home.  she said itchy throat continues to get better.  Reminded to go to E.R if symptoms worsens
Patient had a positive at home test, was admitted to to hospital due to pulmonary effusion on 2/8/22. Patient later passed away 2/16/22.
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 42-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 22-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The pharmacist called about administration of expired moderna vaccine that were given as booster shot around 490 to 500 people.The vaccine was stored in freezer, pharmacist took out one to two vials and place in fridge each day as needed. No concomitant medication was provided. No treatment given to patients.
received injection before noon, by 1800 reported mild chills.  After midnight, chills became worse, temp=101.6.  Severe chills 0400, diaphoresis.  0900 body aches, especially back and legs.  swollen axillary lymph node on arm of injection.  Began vomiting intermittently until 1630.  two days  post injection awoke fully recovered with exception of tender, swollen axillary lymph node on arm of injection.
Information has been received from a pharmacist concerning her 7 year old daughter with eczema, asthma, sulfonamide allergy, egg allergy, hypersensitivity to soy and a peanut allergy, who in approximately 2004 was vaccinated with varicella virus vaccine live (Oka/Merck). Concomitant therapy included Cutivate, Pulmicort and albuterol as needed. In October 2006, "about three years after receiving varicella virus vaccine live (Oka/Merck)", the patient developed warts on her hands and arms. Medical attention was sought and she has had over 100 laser therapy treatments for the warts. No lab studies were performed. At the time of the report the patient had not recovered. No other information has been provided. There was no product quality complaint involved. Additional information is not expected.
Vaccine given on 10/20/17. On 10/21/17, patient woke up crying with arms abducted and flexed. She was lying supine. Was not holding posture. Eyes were fixed. Lasted 2-3 mins. No postictal symptoms. Flu given 36 hrs prior to event.
04Sep90 pt vax w/ hepta b. 5 hrs later devel itching, urticaria, and fine erythematous rash w/ blanching over extremities and trunk.  Tx included DPH and Atarax.
Patient had SHINGRIX vaccine on 2/11/19, he had Zoster 2-3 years ago around right eye and abdomen. He developed a Zoster rash around right eye 2 days after the vaccine.
felt sick; This case was reported by a pharmacist via call center representative and described the occurrence of feeling unwell in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was unknown.   It was unknown if the reporter considered the feeling unwell to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The pharmacist reported that the patient felt sick, and did not specify or elaborate, after receiving 1st dose of Shingrix. The pharmacist did not wish to be contacted or provide any details.
Large red swelling on the arm that received the shot. The swelling grew rapidly to reach from shoulder to elbow. Went to urgent care, where the doctor diagnosed it as cellulitis and prescribed antibiotics.
This was my booster shot for Moderna. I did not experience the following symptoms for my first two doses.  I began itching on my stomach the evening reported. This itching progressed and became intense on the palms of my hands and my feet for the next several days. On 11/28/21 I noticed that when I itched my torso or neck, white/red welts/hives appeared where I itched. This has continued. The itching on my hands and feet as gotten better but has not completely gone away. I have not changed anything, to my knowledge that would have brought on this type of reaction; no change in diet, clothes, detergents, etc. I have also found that my skin feel sensitive to clothing that I have previous worn and has never caused me discomfort. Hot showers also irritate my skin and aggravate the itching.
Swollen; red; hard; Headache; arm was a little tender; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), VACCINATION SITE PAIN (arm was a little tender), VACCINATION SITE SWELLING (Swollen), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE INDURATION (hard) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included OMEPRAZOLE, MULTIVITAMIN [VITAMINS NOS], ACETYLSALICYLIC ACID (BABY ASPIRIN), ASCORBIC ACID (VITAMIN C ACID) and CALCIUM for an unknown indication.    On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced HEADACHE (Headache) and VACCINATION SITE PAIN (arm was a little tender). On 05-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swollen), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE INDURATION (hard). At the time of the report, HEADACHE (Headache), VACCINATION SITE PAIN (arm was a little tender), VACCINATION SITE SWELLING (Swollen), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE INDURATION (hard) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable  No treatment reported.
I was given the first of two SHINGRIX vaccines on Sunday, May 6th. On Wednesday, May 15 I felt what I thought was a bug bite. On Thursday, May 16th a red semi-circle spot appeared on my neck. Two days later another smaller spot appeared on my neck. I thought it was a bug bite but it did not itch. I had some discomfort turning my head and some radiating pain but it was mild. The following Tuesday, May 23rd I went to an urgent care facility where I was diagnosed with Shingles.  I was given Valaciclovir HCL 1 gram which I took three times a day for seven days. The mild radiating shooting pain subsided by weeks end. Shooting pain subsided.
Fatigue, malaise, body aches, muscle aches, joint pain, nausea, diarrhea for first two days, decreased appetite, headaches, inability to sleep for more than an hour due to being so uncomfortable, occasional chills/hot flashes but no fever, told that I look very pale compared to my normal paleness. It has been 6 days since I got my second covid shot.
Possible TIA (diagnosed in Urgent Care); loss of balance; dizziness; headaches; neck pain; blurred vision/blurry eye (right); right arm/leg weakness; This is a spontaneous report from a contactable consumer (the patient). A 40-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown due to it was never shown vial, just administered injection by nurse) via an unspecified route of administration in left arm on 16Apr2021 18:00 at age of 40-year-old at single dose for COVID-19 immunisation. Relevant medical history was "none". No known allergies. Concomitant medications included levocabastine hydrochloride (ZYRTEC) taken for an unspecified indication from an unspecified date, and multivitamin. The patient did not take other vaccine in four weeks. No COVID prior vaccination. COVID not tested post vaccination. The patient experienced Possible TIA (diagnosed in Urgent Care), loss of balance, dizziness, headaches, neck pain, blurred vision, right arm/leg weakness, blurry eye (right). The events onset date was provided as "18Apr2021 10:00 a.m.". The events resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Life threatening illness (immediate risk of death from the event). No treatment received for the events. The outcome of the events was not recovered.  Information about lot/batch number has been requested.
MUSCLE PAIN; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The Batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced muscle pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of muscle pain was not reported. This report was non-serious.
w/in less than 24hr p/vax 17SEP lt arm upper red, sore , hot to touch (involves upper 2/3 of arm)
PT reported onset of rashes day she had: received Hep B vax dose #2 and also eaten pizza at a hospital cafeteria. ? causality factor of "hives". Has subsequently concerned(?) Same food from same cafeteria - no reaction. Hives resolved w/Benadryl PO w/in same day.
This spontaneous report was received from a Licensed vocational nurse (LVN), referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. On an unknown dates, the patient was vaccinated with the three dose series GARDASIL 9 (route, dose, frequency, anatomical location, lot # and expiration date were unknown). The nurse reported the third dose was administered too soon clarified as two months after the second dose was administered. No adverse effects were reported.
Swelling of lymph node; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swelling of lymph node) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported. ).    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced LYMPHADENOPATHY (Swelling of lymph node). At the time of the report, LYMPHADENOPATHY (Swelling of lymph node) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
congestion; coughing; sore throat; had a little soreness; This is a spontaneous report from a contactable consumer. This consumer reported for herself and another one patient (Mother). This is 1st of 2 reports and consumer reported for herself. A 74-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot Number: EN6200), dose 1 via an unspecified route of administration, administered in right arm on 18Feb2021 (at the age of 74-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Medical history included COVID-19 (Additional information for other conditions: had COVID previously in Oct2020) from Oct2020 to an unknown date. Other products reported as unknown. Investigation assessment reported as no. Concomitant medications, history and investigations: Patient stated that there was nothing relevant. Caller states that she has been on the same medications for years now, there was nothing new. No further details were provided. Patient woke up on 22Feb2021 with a little sore throat and not feeling good, and then it went into chest, congestion, coughing up, so patient had the side effects more than a week now. Patient stated that she took Nyquil and Mucinex and stuff to help. Patient heard from other people that the second dose of the Pfizer vaccine has worse side effects than the first dose. Patient would like to know if this was accurate and percentage of efficacy after one dose. The outcome of the events were recovering.   No follow up attempts are possible. No further information is expected.
received second dose of moderna on 6/28/2021.  on first day had fatigue. second day had fever, achy, fatigue, sore throat,  rash on left arm which lasted until 7/1/2021. starting  today SOB, heart palpitations, chest heaviness and burning.  has been taking pre prescribed prescription of albuterol.
Fatigue, headache, nausea, blanched, erythematous rash. No point arches.
Fainted followed by extreme vertigo symptoms and extreme nausea 16 hours after 2nd dose injection. Symptoms lasted for 24 hours
Complained of chest pain, Shortness of breath, dizziness initially. BP 86/54, P 58, O2 sat 99%  Note: Client had been working in migrant field in 95 degree heat for 3 hours prior to vaccine and also appear deheydrated.   Symptoms resolved after placed in Trendelenberg position and hydrated with PO fluids  Client signed EMS waiver declining to be transported to hospital.
PATIENT RECEIVED A SUBCUTANEOUS INJECTION TO HER LEFT ARM. NO ADVERSE EVENTS OCCURRED. PATIENT WAS UNABLE TO RECEIVE AN INTRADERMAL INJECTION, THEREFORE VACCINE WAS ADMINISTERED SUBCUTANEOUSLY.
About 15 minutes, post vax, the pt returned to nursing and reports that he was having a bad taste in his mouth, no other symptoms. Spoke with doctor who advised us to tell pt to wait an additional 15 minutes. Later, pt's friend came back to say it has been 15 minutes and he is fine and can they leave. Then pt got up and was staggering and almost fell and was assisted back to his seat by his friend and another person in the lobby. Nursing was called to the lobby and pt was taken to Life Support. Pt cold and clammy, color pale, BP 177/79, HR-80. Another MD saw pt and he described the bad taste in his mouth as "a metal taste" and got "swimmy headed". The MD exam revealed chest was clear, cardiovascular-RRR without murmurs; abdomen and midline superior abdomen had hernia. Pt reports that he feels better and was released to home.
pain in leg from knee to joint at top of leg , pain in that joint & around too hip.  Pain in top of arms, pain in elbow joints.  Pain in back of neck.
I was having episodes of dyspnea and non productive cough starting from 1/1/2021. On 1/13/2021 I experienced severe dyspnea and had loss of consciousness for 5 seconds and was found down.  I was rushed to the hospital and diagnosed with multiple pulmonary embolus  (about 9) which was treated with direct TPA via catheterization. I then recovered in the ICU and transitioned to oral anticoagulation and discharged home on 1/15/2021.
I had pain in my lower abdomen and lower back. I went to the doctor and had tests run. I had an abnormal pap smear come back and I am expected to go back on September 14 for further testing.